RU2302240C2 - Производные карбаматов для предотвращения или лечения психотических нарушений - Google Patents
Производные карбаматов для предотвращения или лечения психотических нарушений Download PDFInfo
- Publication number
- RU2302240C2 RU2302240C2 RU2003128983/14A RU2003128983A RU2302240C2 RU 2302240 C2 RU2302240 C2 RU 2302240C2 RU 2003128983/14 A RU2003128983/14 A RU 2003128983/14A RU 2003128983 A RU2003128983 A RU 2003128983A RU 2302240 C2 RU2302240 C2 RU 2302240C2
- Authority
- RU
- Russia
- Prior art keywords
- formula
- group
- disorder
- enantiomer
- psychotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27188901P | 2001-02-27 | 2001-02-27 | |
| US60/271,889 | 2001-02-27 | ||
| US10/081,761 | 2002-02-21 | ||
| US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003128983A RU2003128983A (ru) | 2005-03-10 |
| RU2302240C2 true RU2302240C2 (ru) | 2007-07-10 |
Family
ID=26765939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003128983/14A RU2302240C2 (ru) | 2001-02-27 | 2002-02-21 | Производные карбаматов для предотвращения или лечения психотических нарушений |
Country Status (25)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL365701A1 (en) * | 2000-07-21 | 2005-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| WO2003007934A1 (en) | 2001-07-16 | 2003-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| MXPA03007720A (es) | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
| DE60220043T2 (de) * | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen |
| EP1744750A2 (en) * | 2004-05-06 | 2007-01-24 | Sandoz AG | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| EP1928451B1 (en) * | 2005-07-26 | 2011-12-28 | SK Biopharmaceuticals Co., LTD | Methods for treating substance-related disorders |
| CN101568362A (zh) * | 2006-10-30 | 2009-10-28 | 詹森药业有限公司 | 治疗抑郁症的方法 |
| JP2010508354A (ja) * | 2006-10-31 | 2010-03-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 広汎性発達障害の処置 |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| JP6062077B2 (ja) | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes} |
| WO2014142547A1 (en) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for neuroprotection comprising the same |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US278380A (en) * | 1883-05-29 | Thermometer | ||
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| RU2023712C1 (ru) * | 1989-06-09 | 1994-11-30 | Дзе Апджон Компани | Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US6103759A (en) * | 1996-01-16 | 2000-08-15 | Sk Corporation | Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
-
2002
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en not_active Ceased
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko not_active Expired - Lifetime
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
-
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US278380A (en) * | 1883-05-29 | Thermometer | ||
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| RU2023712C1 (ru) * | 1989-06-09 | 1994-11-30 | Дзе Апджон Компани | Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US6103759A (en) * | 1996-01-16 | 2000-08-15 | Sk Corporation | Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol |
Non-Patent Citations (2)
| Title |
|---|
| КАПЛАН Г. и др. Клиническая психиатрия. - М.: ГЭОТАР МЕДИЦИНА, 1994, с.124. VOVIN R.Ia. et al. Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987; 87(9):1396-400. * |
| Психиатрия. / Под ред. Р.Шейдера. - М.: Практика, 1998, с.420. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101335941B1 (ko) | 수면-각성 장애의 치료 | |
| KR20120080656A (ko) | 주의력 결핍/과잉행동 장애(adhd)의 치료 방법 | |
| JP2008542378A (ja) | 精神病性障害を管理する方法および組成物 | |
| KR100858232B1 (ko) | 카바메이트 화합물을 포함하는 거동 장애 예방 또는 치료용 약제학적 조성물 | |
| US6541513B2 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| US20250122164A1 (en) | N,n-dimethylamphetamine analogs for treating brain disorders | |
| HK1247847A1 (zh) | 四氢-N,N-二甲基-2,2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途 | |
| CA3179105A1 (en) | The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia | |
| AU2002242296A1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| KR20080089414A (ko) | 우울증 치료를 위한 벤조-융합된 헤테로사이클 설파미드유도체의 용도 | |
| RS51790B (sr) | Upotreba derivata benzo-kondenzovanih heterocikličkih sulfamida za lečenje manije i bipolarnog poremećaja | |
| EA015566B1 (ru) | Применение пептидного соединения для добавочной терапии к антагонисту дофамина и фармацевтическая композиция, его содержащая | |
| DE60210960T2 (de) | Carbamat-verbindungen zur prävention oder behandlung von angstzuständen | |
| AU2005335241B2 (en) | Methods for treating substance-related disorders | |
| US20060167026A1 (en) | Antipsychotic molecular-targeting epithelial growth factor receptor | |
| ZA200307469B (en) | Carbamate compounds for use in preventing or treating psychotic disorders. | |
| WO2005077367A1 (en) | 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-2s-phenyl-piperidin-3s-yl)-amine for the treatment of social phobia | |
| Witkin et al. | Protection Against Cocaine Toxicity in mice by the DopamineD3/D2 Agonist (+)-PD-128,907 | |
| HK1209058B (en) | Compositions for treating drug addiction and improving addiction-related behavior |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20190207 |
|
| PD4A | Correction of name of patent owner | ||
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20190506 |